February 24, 2011 / 11:44 AM / 8 years ago

UPDATE 1-Integra Lifesciences Q4 tops Street

* Q4 adj EPS $0.80 vs est $0.73

* Q4 rev up 6 pct to $194.1 mln

* Sees FY adj EPS $2.87-$3.02 vs est $2.99 (Follows alerts)

Feb 24 - Medical device maker Integra LifeSciences Holdings Corp posted quarterly results that breezed past market estimates helped by strong sales in its orthopedics and neurosciences segments.

The Plainsboro, New Jersey-based company sees adjusted earnings of $2.87-$3.02 a share on revenue of $765-$780 million for 2011.

Analysts were expecting earnings of $2.99 a share on revenue of $773.4 million, according to Thomson Reuters I/B/E/S.

For October-December, Integra posted net income of $18.8 million, or 63 cents a share, compared with $15.7 million, or 53 cents a share, a year ago.

Excluding items, the company earned 80 cents a share. Revenue rose 6 percent to $194.1 million.

Analysts on average had expected earnings of 73 cents a share, excluding special items, on revenue of $193.1 million.

Orthopedics sales grew 8 percent and Neurosurgery 9 percent. (Reporting by Rajarshi Basu in Bangalore; Editing by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below